Virus Safety Services
Virus Safety Services (VSS) has more than twenty years experience in performing virus validation studies of cellular blood products, plasma-derived products, and other biologicals. We offer a complete range of virus systems compliant with the latest requirements of international regulatory bodies.
Why work with us?
VSS has ample experience with validation of various process steps, including the more delicate ones, like column and nanofiltration steps. VSS has state-of-the art biosafety level (BSL) 3 facilities, including strict separation between virus negative and virus positive areas. All projects are performed according to the principles of Good Laboratory Practices.
VSS provides you with tailor-made solutions:
- We offer detailed information on the virus reducing capacity of process steps studied.
- We use dedicated experimental designs for demonstrating robustness.
- We give you accurate insight into viral safety of a product.
VSS is compliant with the latest requirements of international regulatory bodies
- Note for guidance on plasma-derived medicinal products (CPMP/BWP/269/95 rev. 3, London, 25 Jan. 2001).
- Note for guidance on virus validation studies: The design, contribution and interpretation of studies validating the inactivation and removal of viruses; Revised (CPMP/BWP/268/95, London, 14 February 1996).
- Viral Safety Evaluation of Biotechnology Products Derived from Cell lines of Human or Animal Origin (CPMP/ICH/295/95).